IPO radar | Is KIMS a dark horse in the making?
The growth strategy at KIMS is based on volume play driven by hinterland opportunities
June 17, 2021 / 02:30 PM IST
IPO | (PC-Shutterstock)
PRO Only Highlights
Quarterly performance largely backed by improved realisations
Medium-term triggers China plus and protectionist measures for tyre industry
Valuations not inexpensive; but improved medium-term outlook
The IPO of KIMS (Krishna Institute of Medical Sciences Limited) comes at a time when the domestic pharma/healthcare/diagnostic industry is in the thick of action.
Manipal Hospitals recently acquired Columbia Asia Hospitals for Rs 2,100 crore. The last major deal in this space was in 2018, when IHH Health bought Fortis Healthcare. In times to come, we might witness a pickup in interest from domestic/international majors as the domestic healthcare industry consolidates.
At the same time, as healthcare players foray to...